Skip to main content
Premium Trial:

Request an Annual Quote

William Hawkins and Nicholas Nacleiro

Baebies has appointed William Hawkins and Nicholas Nacleiro to its board of directors. Hawkins has held several leadership positions at Medtronic, including chairman and CEO. Prior to Medtronic, he held senior leadership positions at several prominent healthcare companies, including Johnson & Johnson and Eli Lilly. Nacleiro is a founding partner of Illumina Ventures. Previously, he served as senior vice president of corporate and venture development at Illumina, and co-founded or served in leadership positions at numerous diagnostic and life science firms, including Quanterix, ParAllele Bioscience, True Materials, and Motorola Life Sciences.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.